2-27025616-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_012326.4(MAPRE3):c.503A>T(p.Asn168Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000208 in 1,442,624 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_012326.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAPRE3 | NM_012326.4 | c.503A>T | p.Asn168Ile | missense_variant | 5/7 | ENST00000233121.7 | NP_036458.2 | |
MAPRE3 | NM_001303050.2 | c.503A>T | p.Asn168Ile | missense_variant | 5/7 | NP_001289979.1 | ||
MAPRE3 | NM_001410716.1 | c.458A>T | p.Asn153Ile | missense_variant | 5/7 | NP_001397645.1 | ||
MAPRE3 | XM_047443728.1 | c.503A>T | p.Asn168Ile | missense_variant | 5/7 | XP_047299684.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAPRE3 | ENST00000233121.7 | c.503A>T | p.Asn168Ile | missense_variant | 5/7 | 1 | NM_012326.4 | ENSP00000233121.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000208 AC: 3AN: 1442624Hom.: 0 Cov.: 32 AF XY: 0.00000140 AC XY: 1AN XY: 716134
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 20, 2024 | The c.503A>T (p.N168I) alteration is located in exon 5 (coding exon 4) of the MAPRE3 gene. This alteration results from a A to T substitution at nucleotide position 503, causing the asparagine (N) at amino acid position 168 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at